Supplementary Figure 2 from Phase 1 Open-Label, Multicenter Study of First-in-Class RORγ Agonist LYC-55716 (cintirorgon): Safety, Tolerability, and Preliminary Evidence of Antitumor Activity
openalex（2023）
Key words
cytokine signaling
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined